Accutest Research Lab announced that the company has appointed Dr. Milan C Satia as its chief scientific officer.

A Ph.D. in Pharmacology with wide knowledge base and experience of varied facets of pharmaceutical field including pharmacology, toxicology, bioavailability and bioequivalence studies, clinical trials, and exposure to international audits, Dr Satia has more than 100 bioequivalence studies in his basket, which were carried out in a capacity of principle or co-investigator, that were submitted to WHO, South Africa, Brazil, and European regulatories.

Dr. Satia comes to Accutest with, more than 14years of experience in the pharmaceutical sector where he held various leadership positions. He was with Zydus Cadila as general manager pharmacokinetics, Pharmaceutical Technology Centre (PTC) since Jan 2006, an Accutest press release said.

"With Dr. Satia's expertise and vast knowledge in the field of clinical research, we look forward to further strengthen our systems and processes and keep up with the emerging trend in the industry," said Dr Santosh Joshi, director and co-founder, Accutest Research Lab.

Accutest Research Lab a premium Clinical Research Organization is a three-centred organization with its corporate office located at Navi Mumbai, Pune and Ahmedabad. Each of the centres is functioning as an independent CRO, with Clinical Processing Unit, Bio-Analytical lab, Quality Assurance, Data Processing Cell and the Statistical team.